Metabolic Syndrome and Schizophrenia: Life-Style and Iatrogenic Factors
Friday, March 21st 2014
At the end of this presentation, those in attendance will be able to:
- Review the risk factors for the metabolic syndrome
- Discuss the factors that cause metabolic dysregulation and early mortality in schizophrenia
- Compare the metabolic profile of antipsychotic drugs as revealed in FDA trials and the CATIE study
Target Audience: The webinar is designed primarily for prescribing providers that include Physicians, Nurse Practitioners, and Physician Assistants. Other health professionals within the health center are welcome to attend however, the question and answer period is limited to prescribing providers to address the needs of the primary audience.
Henry Nasrallah, M.D.
Dr. Henry Nasrallah is a widely recognized neuropsychiatrist, educator and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as chair of the Ohio State University Department of Psychiatry for twelve years. In January 2003, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience. In October 2013, he joined St. Louis University as the Sydney W. Souers Endowed Chair and Professor and chairman, Department of Neurology and Psychiatry.
Dr. Nasrallah’s research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published 380 scientific articles, 440 abstracts, as well as 11 books. He is Editor-In-Chief of two journals (SCHIZOPHRENIA RESEARCH and CURRENT PSYCHIATRY) and is the co-founder of the Schizophrenia International Research Society (SIRS). He is board certified in both adult and geriatric psychiatry. He is a distinguished fellow of the American Psychiatric Association, and has served as president of the Cincinnati Psychiatric Society and as president of the American Academy of Clinical Psychiatrists. He has twice received the NAMI Exemplary Psychiatrist Award and was chosen as the U.S.A. Teacher of the Year by the Psychiatric Times. He has received over 85 research grants and is listed in several editions of the book “Best Doctors in America”.
Ronald B. Margolis, Ph.D.
CEO, St. Louis Behavioral Medicine Institute
Professor of Family and Community Medicine at Saint Louis University